Lord Jim O’Neill
Jim O’Neill is a member of the House of Lords, sitting on the cross benches, since he stepped down as Commercial Secretary to the Treasury in September 2016.
In July 2018, Lord O’Neill became Chair of Chatham House, the international think tank.
Jim is also Chairing the International Advisory Board for the Productivity Insights Network+ Programme, co-ordinated by Sheffield University.
Jim continues to be active in Antimicrobial Resistance (AMR), having chaired a independent Review into AMR for the Cameron Government, helping drive HM Government’s strategy as well as providing key input to the United Nations high level agreement in 2016. He recently published a new book on AMR with two of his colleagues from the Review.
Jim chaired the Cities Growth Commission in the UK, which formed the basis for the government’s approach to devolution and the concept of the Northern Powerhouse. He is now Vice Chair of The Northern Powerhouse Partnership.
He is Honorary Chair of Economics at Manchester University.
Jim, creator of the acronym “BRIC”, worked for Goldman Sachs from 1995 until April 2013, spending most of his time there as Chief Economist.
He is a board member and a founding trustee of the UK educational charity, SHINE. Jim has served on the boards of a number of educational foundations.
Stef Bronzwaer works at the European Food Safety Authority (EFSA), initially on the monitoring of antimicrobial resistance and food-borne outbreaks, later to lead the scientific cooperation with the Member States, and now as EFSA’s Research Coordinator: informing research agendas, promoting food research priorities, and coordinating EFSA’s research involvement.
He graduated as medical doctor at the University of Amsterdam and completed his PhD at the University of Groningen (the Netherlands). As a medical doctor he worked shortly at the Social Medical Centre ‘Bukas Palad’ in a slum-area near Manila, the Philippines. He then moved to the Infectious disease unit of the Istituto Superiore di Sanità in Rome, Italy, where he worked as project manager of an EU-project on communicable diseases.
From 1998 to 2002 he worked in the Dutch National Institute for Public Health and the Environment (RIVM), where he helped establish the European Antimicrobial Resistance Surveillance System (EARSS), as project leader. From 2002 to 2005 he worked at the European Commission in Luxembourg where he held responsibility for several European surveillance networks on communicable diseases and followed the implementation of the Community strategy against antimicrobial resistance.
Prof. Martin Cormican, MB, BCh, BAO and MD, member of the Royal College of Physicians (UK) and a Fellow of the Royal College of Pathologists. He is lead of the HSE Antimicrobial Resistance and Infection Control Team, Chair of the Discipline of Bacteriology at NUI, Galway, and Consultant Microbiologist at Galway University Hospitals, Director of the National Salmonella Shigella and Listeria Reference Laboratory, Director of the National Carbapenemase Producing Enterobacteriaceae (CPE) Reference Laboratory, Director of the Centre for Health from Environment at the Ryan Institute NUI Galway. He is also a member of the Scientific Steering Board of the One Health European Joint Programme, a member of the National Public Health Emergency Response Team, and a member of the National CPE Expert Group. He was a member of the Food Safety Authority of Ireland (FSAI) Scientific Committee and the FSAI Biological Safety subcommittee for 15 years. He has over 25 years’ experience of research on antimicrobial resistance. He has over 200 publications. He will inform identification of key stakeholders, facilitate contact with same and advise on development of key intervention points.
Dr. Arie Havelaar is a Preeminent Professor in the Animal Sciences Department, the Institute for Sustainable Food Systems and the Emerging Pathogens Institute of the University of Florida, Gainesville, FL, USA.
His research focuses on epidemiology and risk assessment of foodborne and zoonotic diseases and their prevention. He has published extensively on the global burden of foodborne disease. He contributes to the Feed the Future Innovation Lab for Livestock Systems, leads the “Campylobacter Genetics and Environmental enteric Dysfunction (CAGED)” project and participates in several other projects focusing on food safety in low- and middle-income countries.
Dr. Karin Johansson, European Centre for Disease Prevention and Control